Results 151 to 160 of about 73,118 (265)

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum, Milli McMenamin, Tessa Khoo, John M. Edwin, Prathibha Jose, Liam A. O’Callaghan   +5 more
wiley   +1 more source

Current Perspectives on Radiosensitizers in Cancer Radiotherapy. [PDF]

Int J Nanomedicine
Ruan H, Li Y, Chen S.
europepmc   +1 more source

Contrast Enhancement of High-energy Radiotherapy films

Japanese Journal of Radiological Technology, 1980
openaire   +2 more sources

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Lung ion-fluoroscopy Guided Hadron therapy: LIGHT concept and proof-of-principle. [PDF]

Phys Med Biol
Shaikh S, Simard M, Hetzel R, Dick M, Weber U, Baumann KS, Graeff C, Collins-Fekete CA, Volz L.   +8 more
europepmc   +1 more source

ESR Dosimetry Of High Energy Radiation In Radiotherapy

Journal of Medical Physics, 1992
openaire   +1 more source

Overcoming intranasal delivery barriers with ultrastable polyzwitterionic siRNA nanocages for enhanced glioblastoma therapy

BMEMat, EarlyView.
A ROS‐responsive, zwitterionic nanocage enables stable, intranasal siRNA delivery to glioblastoma, promoting deep tumor penetration via non‐degradative pathways and trigeminal nerve transport. This platform achieves durable gene silencing and tumor suppression, offering a non‐invasive, storage‐stable strategy for treating glioma and other neurological ...
Jingwen Xie, Jingxing Si, Xiaobei Deng, Jing Tan, Ruijie Zhu, Jizhou Qi, Gaoxia Ma, Bin Wang, Yi Wang, Yunzhou Guo, Yuping Chen, Shiqun Shao, Youqing Shen   +12 more
wiley   +1 more source

Does Curative Radiotherapy Impact Fatigue Onset in Prostate Cancer Patients? An Analysis of 1253 Patients. [PDF]

Cancer Rep (Hoboken)
Ferro M, Cilla S, Macchia G, Limosani G, Bonome P, Mastrogiorgio G, Picardi V, Romano C, Ferro M, Boccardi M, Pezzulla D, Buwenge M, Morganti AG, Deodato F.   +13 more
europepmc   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

Photon-counting CT for radiotherapy: Qualitative assessment of potential clinical value by semi-structured expert interviews. [PDF]

Clin Transl Radiat Oncol
Kroes-Kobus T, Rossi L, Nuyttens JJME, de Ruysscher DKM, Odink AE, Olofsen-van Acht MJJ, de Pree IMN, Oei EHG, Elbers JBW, Kroesen M, van der Eerden AW, Mens JWM, Nagtegaal SHJ, de Witte D, Franckena M, Vermaas-Fricot SFN, Middelburg-van Rijn JG, Mendez Romero AM, Willemssen FEJA, Schoots IG, Wohlfahrt P, van Straten M, Hoogeman MS.   +22 more
europepmc   +1 more source